Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Cardiogen cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established Cardiogen cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Cardiogen combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Cardiogen cycle length?
No. We found no human studies that report a treatment duration for Cardiogen.
What is the longest human study of Cardiogen?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Cardiogen dosing reference Full research page

References

  1. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats Bulletin of Experimental Biology and Medicine. 2009
  2. The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats (in Russian) Advances in Gerontology (Uspekhi Gerontologii). 2006
  3. Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging (in Russian) Advances in Gerontology (Uspekhi Gerontologii). 2010
  4. US 7,662,789 B2 — Peptide substance restoring myocardium function (claims Ala-Glu-Asp-Arg; inventors Khavinson, Ryzhak, Grigoriev, Ryadnova) United States Patent and Trademark Office (granted patent). 2010
  5. Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides Biochemistry (Moscow). 2013
  6. PubMed query for "cardiogen" (81 records, of which three concern the peptide; most concern the unrelated French Cardiogen cardiac amyloidosis network) PubMed / NCBI Entrez (U.S. National Library of Medicine). 2026
  7. PubChem compound name lookup for "Cardiogen" (resolves to CID 10917, L-carnitine — an unrelated homonym, not the peptide) PubChem, U.S. National Library of Medicine. 2026
  8. openFDA Drug Label API query returning CardioGen-82 (rubidium Rb-82 generator, Bracco Diagnostics, NDA019414) — an unrelated product with a similar name U.S. Food and Drug Administration / openFDA. 2026
  9. ClinicalTrials.gov registry query for "cardiogen" (4 records, all unrelated cardiovascular genetics and amyloidosis studies retrieved by name matching) ClinicalTrials.gov (U.S. National Library of Medicine). 2026
  10. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) U.S. Food and Drug Administration. 2026
  11. World Anti-Doping Code International Standard — Prohibited List 2026 (effective 1 January 2026) World Anti-Doping Agency. 2026
  12. MeSH / NCBI Entrez query for "cardiogen" (0 records) Medical Subject Headings, U.S. National Library of Medicine. 2026